
Visin0.2%+0.36%
Popular Pharmaceuticals Ltd.
Glycerol + Hypromellose + Polyethylene Glycol 400 is an ophthalmic lubricant (artificial tears) combination indicated for: Established/OTC-monograph use: Temporary relief of burning, irritation and more.
Glycerol + Hypromellose + Polyethylene Glycol 400 is an ophthalmic lubricant (artificial tears) combination indicated for:
This is a symptomatic, supportive therapy; it does not treat the underlying cause of dry eye disease and does not replace evaluation for persistent or worsening symptoms.
Glycerol + Hypromellose + Polyethylene Glycol 400 is dosed as follows:
| Population | Dose | Frequency |
|---|---|---|
| Adults | 1-2 drops in the affected eye(s) | As needed, typically 3-4 times daily or more frequently if required |
| Children | 1-2 drops in the affected eye(s) | As needed under adult supervision; consult a physician for use in young children |
Shake the bottle gently before use if indicated on the product label. Tilt the head back, pull down the lower eyelid to form a small pocket, instill the drop(s), and close the eye gently for 1-2 minutes. Avoid touching the dropper tip to the eye or any surface to prevent contamination.
Glycerol + Hypromellose + Polyethylene Glycol 400 is generally very well tolerated, as it is minimally to not systemically absorbed. Reported effects are typically local and transient:
If eye pain, marked redness, vision changes, or discomfort persists beyond 72 hours or worsens, discontinue use and seek medical advice (see Precautions).
Glycerol + Hypromellose + Polyethylene Glycol 400 is contraindicated in patients with known hypersensitivity to glycerol, hypromellose, polyethylene glycol 400, or any other component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.